Items where Author is "Hardmeier, M."

2022

Hardmeier, M. and Schlaeger, R. and Lascano, A. M. and Toffolet, L. and Schindler, C. and Gobbi, C. and Lalive, P. and Kuhle, J. and Kappos, L. and Fuhr, P.. (2022) Prognostic biomarkers in primary progressive multiple sclerosis: validating and scrutinizing multimodal evoked potentials. Clinical neurophysiology, 137. pp. 152-158.

2015

Hatz, F. and Hardmeier, M. and Bousleiman, H. and Rüegg, S. and Schindler, C. and Fuhr, P.. (2015) Reliability of fully automated versus visually controlled pre- and post-processing of resting-state EEG. Clinical neurophysiology, Vol. 126, H. 2. pp. 268-274.

2013

Hatz, F. and Benz, N. and Hardmeier, M. and Zimmermann, R. and Rueegg, S. and Schindler, C. and Miserez, A. R. and Gschwandtner, U. and Monsch, A. U. and Fuhr, P.. (2013) Quantitative EEG and apolipoprotein E-genotype improve classification of patients with suspected Alzheimer's disease. Clinical Neurophysiology, 124 (11). pp. 2146-2152.

2012

Hardmeier, M. and Zimmermann, R. and Rüegg, S. and Pflüger, M. and Deuster, S. and Suter, K. and Donzelli, M. and Drewe, J. and Krähenbühl, S. and Fuhr, P. and Haschke, M.. (2012) Intranasal midazolam: pharmacokinetics and pharmacodynamics assessed by quantitative EEG in healthy volunteers. Clinical Pharmacology & Therapeutics, 91 (5). pp. 856-862.

2008

Mehling, M. and Drechsler, H. and Kuhle, J. and Hardmeier, M. and Doerries, R. and Ruegg, S. and Gass, A.. (2008) Adaptation of antiretroviral therapy in human immunodeficiency virus infection with central nervous system involvement. Journal of neurovirology, Vol. 14, H. 1. pp. 78-84.

Rüegg, S. and Naegelin, Y. and Hardmeier, M. and Winkler, D. T. and Marsch, S. and Fuhr, P.. (2008) Intravenous levetiracetam : treatment experience with the first 50 critically ill patients. Epilepsy & behavior, Vol. 12, H. 3. pp. 477-480.

2004

Penner, I. -K. and Hardmeier, M. and Vogt, A. and Stoecklin, M. and Raselli, C. and Opwis, K. and Radue, E. W. and Kappos, L.. (2004) Experimentally induced fatigue in MS patients. Multiple sclerosis, Vol. 10, no. 7032, Suppl. 2 , S126-S127.

2001

Penner, I. -K. and Rausch, M. and Hardmeier, M. and Opwis, K. and Kappos, L. and Radü, E. W.. (2001) Altered functional activation in MS patients with reduced attentional performance demonstrated with functional MRI. NeuroImage, Vol. 13. p. 347.